Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Webinars
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • AI and healthcare
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
      • Top Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • AI and healthcare
    • Industry Perspective
  • Home
  • News
  • Medical Education
  • Medical Admission News
  • Don't pay anyone! NTA...

Don't pay anyone! NTA warns against rumours, fake papers, scams ahead of NEET 2026 re-exam

Written By : Adity Saha Published On 2026-06-17T15:23:07+05:30  |  Updated On 17 Jun 2026 6:51 PM IST
NTA Opens Scribe Registration Portal for PwD, PwBD Candidates.
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: The National Testing Agency (NTA) has urged parents and candidates not to fall for rumours, fake papers, or Telegram scams promising advanced question papers ahead of NEET UG 2026 re-examination on June 21.

In a social media post on X, Director General Abhishek Singh shared a video on June 16 discussing the fake paper-selling scams, manipulated Telegram chats, and rumours being spread around the NEET Re-Examination.

He explained that scammers on Telegram are running channels demanding money ranging from 14 thousand to 25 thousand rupees and even Rs 10 lakh with claims of sharing the re-exam paper.

He further clarified that there is no leaked paper for the re-exam. "The money is gone the moment you transfer it. Your admit card and WhatsApp number, if you sent them, become the tools they use to scam the next student," he said.

NTA also said that fake "proof" videos showing chats from before the exam are also being circulated. Singh said in the video that the trick on Telegram is that whoever runs a channel can edit any old message and change what's inside it, while the date on the message stays the same. So a message edited on the 4th can be made to look exactly like it was sent on the 1st.

"The same trick will be tried again after 21st June. Don't fall for it. Don't forward it. Don't pay anyone," the agency warned in the social media post.

The video explained how some Telegram channels are falsely claiming to sell NEET question papers, asking students for payments through UPI or cryptocurrency, and using fake screenshots or videos to mislead candidates.

However, NTA stressed that nobody outside the official system has access to the question paper. It said extensive security measures have been put in place for preparing, printing and transporting the exam papers, with support from government agencies and security forces.

"Anyone claiming to sell you any paper is lying, is trying to scam you, is trying to fool you, is trying to exploit your vulnerability," the agency said in the video. It added that no version of the question paper would be available outside the secure chain before 2 pm on June 21.

NTA advised students to focus on their exam preparation and not fall for fake claims. It urged candidates to rely only on information available on the official NTA website and verified NTA social media handles. The agency also asked students to inform their friends about such scams and report any suspicious activity to the National Cyber Crime Helpline (1930) or the Cyber Crime Portal.

"Your hard work is what will get you through this exam. Not a Telegram channel. We're on your side," the agency said.

To every NEET candidate and parent - please watch this. A few minutes that could save you serious money and stress this week.
Scammers on Telegram were running two rackets targeting you:
1️⃣ Channels demanding ₹14,000 to ₹25,000 - some even ₹10 lakh - claiming they'll send you… pic.twitter.com/aqpickJLAv

— National Testing Agency (@NTA_Exams) June 16, 2026

Telegram Banned

Ahead of the NEET UG 2026 re-examination scheduled for June 21, Telegram has been temporarily banned in India in the wake of cheating rackets duping aspirants. The National Testing Agency (NTA) has welcomed the central government's decision to impose temporary restrictions on the Telegram platform.

The Ministry of Electronics and Information Technology (MeitY) has directed that access to Telegram to be restricted in India until June 22, covering the examination day and its immediate aftermath.

In addition, Telegram has been instructed to disable its message-editing feature in India until June 30, addressing the specific structural feature through which the platform has been used to fabricate after-the-event “paper leak” evidence in respect of national examinations.

The measures have been taken in response to several Telegram channels that were allegedly being used by cheating rackets to spread false claims about leaked NEET question papers and to defraud students and their families.

This comes after recent arrest of two Rajasthan-based men by the Cyber Crime Cell which has exposed a large online fraud network that allegedly targeted students and parents with false promises of access to RE-NEET examination papers.

According to police, the duo allegedly operated nearly eight Telegram channels and used them to attract students by posting sensational claims about examination leaks and insider information. Victims were then asked to transfer money through online payment platforms in exchange for the promised material.

The investigators found that over 1,500 students or their kin were cheated of Rs 1.5 crore by the frausters. More arrests are likely in the case.

Telegram moves Delhi HC

Following the temporary ban, Telegram has moved the Delhi High Court challenging the centre's decision. The matter was mentioned urgently before a vacation bench, which agreed to hear the plea later in the day.

Telegram has argued that the restriction has impacted more than 150 million users across the country.

The Centre imposed the temporary block following a request from the National Testing Agency (NTA), which claimed that organised cheating networks were using the platform to circulate fake claims about leaked question papers and defraud NEET aspirants.

While Telegram founder Pavel Durov said the platform had already removed hundreds of suspicious channels and termed the restriction disproportionate, the NTA has maintained that the measure is necessary to ensure a fair and secure conduct of the June 21 re-examination.

According to lawyers appearing in the case, the temporary restriction has affected more than 150 million Telegram users across India.

NEET cancelled

The NEET UG 2026 examination was conducted on May 3 by the National Testing Agency from 2:00 PM to 5:00 PM in pen-and-paper mode. Over 22.7 lakh aspirants appeared for the examination this year. It took place across 551 cities in India and 14 cities abroad, covering over 5,400 centres.

However, on May 12, 2026, the NTA declared the examination held on May 3 cancelled and subsequently announced a re-examination on June 21, 2026.

This came in the backdrop of the probe by the Rajasthan Police Special Operations Group, which reportedly found a “guess paper” containing more than 100 questions similar to those asked in the NEET UG examination. The question paper series under scrutiny has been described as a “guess paper” which reportedly contained around 410 questions. Out of these, nearly 120 questions are alleged to have appeared in the Biology and Chemistry sections of the examination.

In the aftermath of the exam cancellation, protests were held, with aspirants and members of the medical fraternity blaming NTA and the Education Ministry for the failure.

Due to the alleged controversy, the central government decided to refer the matter to the Central Bureau of Investigation for a comprehensive inquiry into the allegations. Based on the centre's direction, the CBI registered an FIR in the case and has so far arrested 13 people.

Also read- NEET 2026 re-exam row: Telegram moves Delhi HC against temporary ban in India

TelegramNEET UGNEET UG 2026NTAneet reexamneet paper leakneet 2026neet cancelled
Adity Saha
Adity Saha

    MA in Journalism and Mass Communication

    Exploring and learning something new has always been her motto. Adity is currently working as a correspondent and joined Medical Dialogues in 2022. She completed her Bachelor’s degree in Journalism and Mass Communication from Calcutta University, West Bengal, in 2021 and her Master's in the same subject in 2025. She mainly covers the latest health news, doctors' news, hospital and medical college news. She can be contacted at editorial@medicaldialogues.in

    Print Article
    Show Full Article
    Next Story

    Editorial

    Key Takeaways on the Emerging Role of PPAR Agonists in MASLD/MASH: ADA 2026 Update

    Key Takeaways on the Emerging Role of PPAR Agonists in MASLD/MASH: ADA 2026 Update

    The AI Imperative: Preparing Indian Medicine for Transformation - Dr Raju Vaishya

    The AI Imperative: Preparing Indian Medicine for Transformation - Dr Raju Vaishya

    Metastatic Prostate Cancer Treated with TPGS-Docetaxel-Based Chemotherapy: A Case Profile - Dr Kaushal Patel

    Metastatic Prostate Cancer Treated with TPGS-Docetaxel-Based Chemotherapy: A Case Profile - Dr...

    Real-World NSCLC Case Study | Concurrent Uncommon EGFR Mutations & ALK Rearrangement Treated with Brigatinib

    Real-World NSCLC Case Study | Concurrent Uncommon EGFR Mutations & ALK Rearrangement Treated with...

    Oral Elagolix Achieves Greater Endometrioma Size Reduction and a Three-Fold Higher Conception Rate Compared to Leuprolide Depot: Indian Study

    Oral Elagolix Achieves Greater Endometrioma Size Reduction and a Three-Fold Higher Conception Rate...

    View All

    Journal Club Today

    Women With Multiple Long-Term Conditions Face Higher Pregnancy Risk: Study

    Women With Multiple Long-Term Conditions Face Higher Pregnancy Risk: Study

    View All

    Health News Today

    Health Bulletin 24/August/2026

    Health Bulletin 24/August/2026

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok